Global Obesity Surgery Device Market Size By Type (Intragastric Balloons, Gastric Electrical Stimulation), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Obesity Surgery Device Market was valued at USD 2.9 billion in 2023 and is projected to reach USD 5.6 billion by 2031, growing at a CAGR of 8.7% during the forecast period from 2023 to 2031. The growing prevalence of obesity worldwide, increasing health awareness, and rising demand for minimally invasive bariatric procedures are driving the market forward. Devices supporting procedures like gastric bands, sleeve gastrectomy, and gastric balloons are witnessing increased adoption, particularly across developed healthcare systems and emerging markets prioritizing obesity-related interventions.

Drivers:

1. Rising Global Obesity Prevalence:

An alarming increase in obesity rates, driven by sedentary lifestyles and unhealthy eating habits, is prompting demand for effective surgical interventions. According to the WHO, over 650 million adults were obese as of 2022—a trend fueling the adoption of surgical solutions globally.

2. Advancements in Bariatric Surgery Technology:

Innovations in laparoscopic and robotic-assisted surgical devices are making procedures safer and more efficient. The evolution of minimally invasive devices significantly reduces patient recovery time and postoperative complications, enhancing adoption.

3. Government and Insurance Support:

Expanding insurance coverage and supportive public health policies in countries like the U.S., Germany, and Japan are improving patient access to obesity treatment devices.

Restraints:

1. High Procedure and Device Costs:

Despite growing awareness, the high cost of surgical procedures and associated devices can deter adoption, particularly in cost-sensitive regions lacking insurance coverage.

2. Surgical Risks and Patient Hesitancy:

Potential complications, such as infections or device malfunction, alongside patient apprehension about undergoing surgery, present a challenge to market expansion.

Opportunity:

1. Untapped Potential in Emerging Economies:

Countries in Asia-Pacific and Latin America are witnessing a surge in obesity rates but still lack sufficient medical infrastructure for widespread obesity surgeries. This creates growth potential for device manufacturers.

2. Integration of AI and Robotics:

Future integration of AI and robotic-assisted surgery offers opportunities to increase precision, reduce surgeon fatigue, and improve patient outcomes, positioning these technologies as market differentiators.

Market by System Type Insights:

The Gastric Band Devices segment led the market in 2023 due to its long-standing adoption and minimally invasive nature. However, the Gastric Balloon Devices segment is expected to exhibit the fastest growth rate during the forecast period, as non-surgical and reversible procedures gain popularity among risk-averse patients.

Market by End-use Insights:

The Hospitals segment accounted for the largest market share in 2023, driven by the availability of advanced infrastructure and specialized surgical teams. Meanwhile, the Ambulatory Surgical Centers (ASCs) segment is expected to grow at the highest CAGR due to the increasing preference for outpatient procedures that reduce costs and hospital stays.

Market by Regional Insights:

North America dominated the market in 2023, supported by high obesity rates, favorable reimbursement policies, and the presence of key players. Asia-Pacific is expected to witness the fastest growth during the forecast period, driven by changing lifestyles, increasing obesity rates, and improving healthcare access in countries like India and China.

Competitive Scenario:

Key players in the Global Obesity Surgery Device Market include:

Medtronic plc

Johnson & Johnson (Ethicon)

Apollo Endosurgery Inc.

B. Braun Melsungen AG

ReShape Lifesciences Inc.

Spatz FGIA Inc.

Cousin Biotech

Allurion Technologies Inc.

Aspire Bariatrics Inc.

Olympus Corporation

These companies are investing in R&D, strategic partnerships, and geographic expansion to gain competitive advantages and develop next-gen bariatric devices.

Scope of Work – Global Obesity Surgery Device Market

Key Market Developments:

2023: Medtronic launched a next-gen robotic-assisted system for bariatric procedures to enhance surgical accuracy and reduce operating times.

2024: Apollo Endosurgery received regulatory approval in Europe for its new non-invasive gastric balloon device with improved biodegradability.

2025: Johnson & Johnson expanded its bariatric device production in Asia to meet regional demand surges due to increasing obesity-related interventions.

FAQs:

1. What is the current market size of the Global Obesity Surgery Device Market?

The market was valued at USD 2.9 billion in 2023.

2. What is the major growth driver of the Global Obesity Surgery Device Market?

The major growth driver is the rising global prevalence of obesity and increasing adoption of minimally invasive surgical technologies.

3. Which is the largest region during the forecast period in the Global Obesity Surgery Device Market?

North America remains the largest region due to high procedure volumes and favorable healthcare reimbursement.

4. Which segment accounted for the largest market share in the Global Obesity Surgery Device Market?

The Hospitals segment accounted for the largest share, driven by advanced surgical infrastructure.

5. Who are the key market players in the Global Obesity Surgery Device Market?

Key players include Medtronic, Johnson & Johnson, Apollo Endosurgery, and ReShape Lifesciences.